Valeritas Holdings, Inc. Announces the Resignation of Rodney Altman, M.D. as Member of the Board of Directors, Effective by September 30, 2019
September 06, 2019 at 04:18 pm EDT
Share
On September 3, 2019, Valeritas Holdings, Inc. was informed by Rodney Altman, M.D., a member of the Company's Board of Directors (the Board"), that he will be resigning as a director of the Company, to be effective by September 30, 2019. Dr. Altman has advised the Company that he is resigning because he accepted a healthcare investing role with a financial services corporation, and the corporation is requiring him to resign from all public company boards.
Valeritas Holdings, Inc. is a United States-based medical technology company. The Company's product, V-Go Wearable Insulin Delivery device (V-Go), is a wearable, basal-bolus insulin delivery device for adult patients requiring insulin that enables patients to administer a continuous preset basal rate of insulin over 24 hours. V-Go is a small wearable and completely disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. V-Go enables patients to closely mimic the body's normal physiologic pattern of insulin delivery throughout the day and to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. It has developed V-Go utilizing its h-Patch platform as a patient-focused solution to address insulin therapies. Its h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.